<DOC>
	<DOCNO>NCT02096848</DOCNO>
	<brief_summary>Studies describe bacterial aetiology antimicrobial susceptibility AOM child Latin America scarce . Interestingly , MEF microbiology analyze among 1,108 child age 2-92 month OM year 2002 2007 , non-typable H. influenzae common pathogen isolate MEF child otitis medium fail appropriate antimicrobial therapy . PCV-7 ( 3 + 1 regimen ) introduce Costa Rican national immunization program January 2009 August/September 2011 , change PCV 13 ( -2+1 regimen ) . Following PCV-7 universal introduction Costa Rica , March 2010 January 2011 , MEF sample Costa Rican child OM , receive 0-4 PCV 7 vaccine dos , obtain via tympanocentesis ( 88 % ) spontaneous otorrhoea ( 12 % ) . It interesting observe among initial 134 OM episode , common bacterial pathogen identify H. influenzae ( 55 % ) follow S. pneumoniae ( 31 % ) among S. pneumoniae episode , 55 % already non-PCV-7 serotypes 25 % isolate multi-drug resistant . The primary objective study analyze effect early universal utilization PCV-13 Costa Rican child number H. influenzae PCV-13- S. pneumoniae positive MEF culture compare data collect prospectively group investigator collect original data since 1992 , child post-PCV-13 introduction anonymised information collect retrospectively pre-PCV-7 data ( 1999-2004 ) transition period PCV-7 use private setting ( 2005-2008 ) universal use PCV-7 ( 2009-September 2011 ) .</brief_summary>
	<brief_title>Microbiology Otitis Media Costarrican Children After PCV13 Introduction</brief_title>
	<detailed_description>Studies describe bacterial aetiology antimicrobial susceptibility AOM child Latin America scarce , however , since 1991 , investigator Costa Rica follow MEF microbiology Costa Rican child AOM include data PCV 7 , period time PCV-7 use among high risk child universal introduction 3 + 1 PCV-7 regimen Costa Rica . Published data Costa Rican child OM , collect 1992 2007 , describe MEF microbiology indicate overall S. pneumoniae frequent pathogen follow non-typable H. influenzae , M. catarrhalis S. pyogenes . Interestingly , MEF microbiology analyze among 1,108 child age 2-92 month OM year 2002 2007 , non-typable H. influenzae mosto common pathogen isolate MEF child otitis medium fail appropriate antimicrobial therapy . PCV-7 ( 3 + 1 regimen ) introduce Costa Rican national immunization program January 2009 August/September 2011 , change PCV 13 ( -2+1 regimen ) . Following PCV-7 universal introduction Costa Rica , March 2010 January 2011 , MEF sample Costa Rican child OM , receive 0-4 PCV 7 vaccine dos , obtain via tympanocentesis ( 88 % ) spontaneous otorrhoea ( 12 % ) . It interesting observe among initial 134 OM episode , common bacterial pathogen identify H. influenzae ( 55 % ) follow S. pneumoniae ( 31 % ) among S. pneumoniae episode , 55 % already non-PCV-7 serotypes 25 % isolate multi-drug resistant . Based available information describe worldwide modification MEF microbiology PCV-7 vaccinate child OM ( proportional increase case cause H. influenzae non-PCV-7 S. pneumoniae serotypes ) , primary objective study analyze effect early universal utilization PCV-13 Costa Rican child number H. influenzae PCV-13- S. pneumoniae positive MEF culture compare data collect prospectively group investigator collect original data since 1992 , child post-PCV-13 introduction anonymised information collect retrospectively pre-PCV-7 data ( 1999-2004 ) transition period PCV-7 use private setting ( 2005-2008 ) universal use PCV-7 ( 2009-September 2011 ) .</detailed_description>
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<criteria>All subject must satisfy follow criterion study entry : Age : 3 month le 6 year time inform consent . The subject become ineligible seven birthday . Signs symptom include : One functional general sign otalgia ( equivalent : irritability ) , conjunctivitis , fever ; AND EITHER Paradise 's criterion ( bulge , diffuse localise inflamed tympanic membrane ) Spontaneous otorrhoea le 24 hour . Hospitalised diagnosis otitis medium treatment . Having otitis externa , otitis medium effusion Presence transtympanic tube . Children present new episode otitis medium receive antibiotic systemic therapy past 3 day separate illness . Receiving antimicrobial prophylaxis recurrent acute otitis medium . Received antibiotic otitis medium last day ( exception : child otitis medium treatment failure must receive antibiotic treatment within 3 5 day prior study inclusion current otitis medium episode ) .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>otitis medium</keyword>
	<keyword>microbiology</keyword>
	<keyword>vaccine</keyword>
</DOC>